SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BARONI, Marcello
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.390
AS - Asia 3.057
EU - Europa 1.706
SA - Sud America 506
AF - Africa 64
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.740
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.239
SG - Singapore 1.177
CN - Cina 729
IT - Italia 425
VN - Vietnam 401
BR - Brasile 376
DE - Germania 309
HK - Hong Kong 233
GB - Regno Unito 194
UA - Ucraina 174
TR - Turchia 119
PL - Polonia 97
JP - Giappone 95
FR - Francia 94
FI - Finlandia 89
CA - Canada 79
RU - Federazione Russa 73
SE - Svezia 64
IN - India 57
MX - Messico 55
ID - Indonesia 52
AR - Argentina 45
BD - Bangladesh 45
NL - Olanda 37
ES - Italia 34
BE - Belgio 30
IQ - Iraq 29
ZA - Sudafrica 27
EC - Ecuador 26
PK - Pakistan 21
CZ - Repubblica Ceca 19
CO - Colombia 16
AT - Austria 15
MA - Marocco 14
AU - Australia 13
PE - Perù 13
LT - Lituania 12
MY - Malesia 12
UZ - Uzbekistan 11
VE - Venezuela 10
CL - Cile 9
AE - Emirati Arabi Uniti 8
SA - Arabia Saudita 8
AZ - Azerbaigian 7
KE - Kenya 7
PH - Filippine 7
IE - Irlanda 6
RO - Romania 6
JO - Giordania 5
UY - Uruguay 5
BA - Bosnia-Erzegovina 4
CR - Costa Rica 4
ET - Etiopia 4
GE - Georgia 4
IL - Israele 4
PS - Palestinian Territory 4
PY - Paraguay 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
TN - Tunisia 4
GT - Guatemala 3
IR - Iran 3
KZ - Kazakistan 3
NP - Nepal 3
OM - Oman 3
PT - Portogallo 3
AL - Albania 2
AM - Armenia 2
BG - Bulgaria 2
EU - Europa 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
KR - Corea 2
LK - Sri Lanka 2
LV - Lettonia 2
NG - Nigeria 2
NI - Nicaragua 2
RS - Serbia 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BZ - Belize 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GY - Guiana 1
HR - Croazia 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
MK - Macedonia 1
Totale 10.734
Salva come PNG Salva come JPEG
Città #
Singapore 751
Ashburn 617
Fairfield 383
San Jose 371
Woodbridge 361
Chandler 274
Beijing 255
Santa Clara 236
Hong Kong 226
Houston 214
Dallas 212
Ann Arbor 190
Ferrara 189
Jacksonville 168
Seattle 168
Wilmington 153
Ho Chi Minh City 132
Cambridge 123
The Dalles 105
New York 101
Munich 93
Warsaw 91
Los Angeles 90
Tokyo 89
Hanoi 84
Boardman 76
Izmir 66
Council Bluffs 60
Nanjing 59
Princeton 56
Lauterbourg 52
Milan 48
Orem 45
Jakarta 42
Shanghai 41
São Paulo 41
Dearborn 37
Mexico City 37
Bremen 32
Helsinki 32
San Diego 31
Brooklyn 27
Brussels 25
Montreal 24
Falls Church 23
Shenyang 23
Denver 22
Haiphong 22
Manchester 22
Nanchang 22
Turku 22
Chicago 21
Da Nang 21
Hefei 21
Toronto 21
London 20
Johannesburg 19
Buffalo 18
Guangzhou 18
Moscow 18
Poplar 18
Frankfurt am Main 17
Brno 16
Redwood City 16
Amsterdam 15
Florence 15
Hebei 14
Norwalk 14
Tianjin 14
Boston 13
Dong Ket 13
Rome 13
Biên Hòa 12
Chennai 12
Jiaxing 12
Phoenix 12
Mcallen 11
Mumbai 11
San Francisco 11
Atlanta 10
Baghdad 10
Columbus 10
Tashkent 10
Verona 10
Zhengzhou 10
Bologna 9
Düsseldorf 9
Quito 9
San Mateo 9
Hải Dương 8
Montréal 8
Rio de Janeiro 8
Stockholm 8
Auburn Hills 7
Augusta 7
Baku 7
Belo Horizonte 7
Can Tho 7
Des Moines 7
Dortmund 7
Totale 7.276
Salva come PNG Salva come JPEG
Nome #
Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study 283
Hemostasis biomarkers in multiple sclerosis 255
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 250
Responsiveness of hemophilia B- causing non sense mutations to ribosome readthrough-inducing drugs strictly depends on the nucleotide and prrotein context 241
Genetic determinants of activated factor VII antithrombin complex plasma concentration include tissue factor, factor VII and endothelial protein C receptor gene variants 238
Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. 237
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 237
Membrane binding and anticoagulant properties of protein S natural variants 235
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 235
The carboxyl-terminal region is not essential for secreted and functional levels of coagulation factor X 220
Factor II Activity is Similarly Increased in Patients With Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele 213
TRATTAMENTO E PREVENZIONE DI MALATTIE CARDIOVASCOLARI CON ACIDO ERUCICO E METODI DIAGNOSTICI CORRELATI 211
Asymmetric processing of mutant factor X Arg386Cys reveals differences between intrinsic and extrinsic pathway activation 207
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 204
The carboxyl-terminal region is NOT essential for secreted and functional levels of coagulation factor X 203
Missense changes in the catalytic domain of coagulation factor X account for minimal function preventing a perinatal lethal condition 203
Human protein S circulates in plasma partially bund to LDL and HDL: do PS-lipoprotein complexes mediate PS delivery within atherosclerotic plaque? 197
Plasma levels of soluble NCAM in multiple sclerosis 192
Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation 186
Factor II Activity is Similarly Increased in Patients with Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele 186
Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes 186
Crosstalk between hemostasis inhibitors and cholesterol biomarkers in multiple sclerosis 183
Expression profiles of the internal jugular and saphenous veins: Focus on hemostasis genes 183
Activated factor VII: antithrombin complex plasma concentration in subjects with or without angiographically demonstrated coronary artery disease and myocardial infarction 179
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 172
Functional recovery in multiple sclerosis patients undergoing rehabilitation programs is associated with plasma levels of hemostasis inhibitors 170
Protein S on the surface of plasma lipoproteins: a potential mechanism for protein S delivery to the atherosclerotic plaques? 162
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 162
Mutation-specific contributions to trace factor X levels account for a life-threating phenotype in a compound heterozygous factor X deficient patient 162
The F7 p.Val22Ile missense mutation affects splicing and can be counteracted by a compensatory U1snRNA 162
Treatment and prophylaxis of cardiovascular disorders with erucic acid and related diagnostic methods 160
Impaired prothrombinase activity of factor X Gly381 Asp results in severe familial CRM+ FX deficiency 158
In Situ Endothelial SARS-CoV-2 Presence and PROS1 Plasma Levels Alteration in SARS-CoV-2-Associated Coagulopathies 156
RNA-based therapeutic approaches for blood coagulation factor deficiencies caused by a splicing mutations 151
Release of Tissue Factor-bearing microparticles by human dendritic cells induced by stimulation of membrane P2X7 receptors 150
Hemostasis gene expression of the internal jugular and saphenous veins 150
CCL18 plasma levels are increased in progressive MS patients and associated with MRI outcomes of tissue injury (P1.396) 148
Reduced activation of the Gla19Ala FX variant via the extrinsic coagulation pathway results in symptomatic CRMred FX deficiency 145
Increased CCL18 plasma levels are associated with neurodegenerative MRI outcomes in multiple sclerosis patients 145
Plasma levels of protein C pathway proteins and brain magnetic resonance imaging volumes in multiple sclerosis 145
Non-conventional therapeutic strategies for inherited disorders of hemostasis 144
THE NATURAL ARG386CYS MUTATION IN THE COAGULATION FACTOR X, AS A TOOL TO INVESTIGATE DIFFERENT FX-REQUIREMENTS IN INITIATION AND PROPAGATION PHASES. 139
Tratamiento y profilaxis de trastornos cardiovasculares con ácido erúcico 137
EFFECT OF SARS-CoV-2 ON THE COAGULATION CASCADE IN COVID-19 ASSOCIATED COAGULOPATHIES 135
West Nile virus non-structural protein 1 promotes amyloid Beta deposition and neurodegeneration 134
Combination of Genomic and Transcriptomic Approaches Highlights Vascular and Circadian Clock Components in Multiple Sclerosis 133
Aptamer-modified FXa generation assays to investigate hypercoagulability in plasma from patients with ischemic heart disease 127
Basophil Blood Cell Count Is Associated With Enhanced Factor II Plasma Coagulant Activity and Increased Risk of Mortality in Patients With Stable Coronary Artery Disease: Not Only Neutrophils as Prognostic Marker in Ischemic Heart Disease 125
Natural mutations in the EGF4 domain of protein S produce extended conformational changes and alter phospholipid and C4bBP interactions 121
Treatment and prophylaxis of cardiovascular disorders with erucic acid and related diagnostic methods 118
The effect of the chemical chaperone 4-phenylbutyrate on secretion and activity of the p.Q160R missense variant of coagulation factor FVII 117
The Factor VII Variant p.A354V-p.P464Hfs: Clinical versus Intracellular and Biochemical Phenotypes Induced by Chemical Chaperones 117
NATURAL MUTATIONS IN THE EGF4 DOMAIN OF PROTEIN S PRODUCE EXTENDED CONFORMATIONAL CHANGES AND ALTER PHOSPHOLIPID AND C4BBP INTERACTIONS 115
RNA−based therapeutic approaches for blood coagulation factor deficiencies caused by splicing mutations 112
Treatment and prophylaxis of cardiovascular disorders with erucic acid and related diagnostic methods 108
Molecular characterization of factor X deficiency associated with borderline plasma factor X level 97
null 94
null 93
Coagulation factor VII variants resistant to inhibitory antibodies 93
Mapping of inhibitory antibodies directed to the carboxy-terminus of FVIIa in severe FVII deficiency with elongated C-terminal variant (p.A354V-p.P464Hfs†) 92
Coagulation factor VII variants resistant to inhibitory antibodies. 91
Suppression of “leaky” nonsense mutations by ribosome readthrough accounts for residual factor IX levels in Haemophilia B patients 86
Plasma levels of hemostasis inhibitors and MRI outcomes in multiple sclerosis (P3.368) 86
Immune response to treatment in a severe factor VII deficient patient: characterization of the inhibitory antibody and epitope-mapping 84
null 84
null 73
Treatment and prophylaxis of cardiovascular disorders with erucic acid and related diagnostic methods 72
Relationships among circulating levels of hemostasis inhibitors, chemokines, adhesion molecules, and mri characteristics in multiple sclerosis 64
null 56
null 45
Flavivirus Nonstructural Protein 1-Driven Coagulation via Tissue Factor-Bearing Microvesicles: A Pilot Study 45
Selected cell receptor genotypes differentially modulate the ABO blood group influence on Factor VIII levels in severe aortic stenosis 33
Natural Mutations in the 4th EGF-Like Domain of Protein S Alter GLA and SHBG Domain Interactions. 26
SARS-CoV-2 Infection Associated with HHV-6A Reactivation and an Inhibitory KIR2DL2/HLA-C1 Immunogenetic Profile 17
Roles of full-length and Δα1 HLA-G isoforms in NK-cell regulation and vascular SARS-CoV-2 infection 15
Genetic determinants of activated factor VII-antithrombin plasma levels and mortality in patients with coronary artery disease 13
SARS-CoV-2 Infection Associated with HHV-6A Reactivation and an Inhibitory KIR2DL2/HLA-C1 Immunogenetic Profile 10
Totale 10.913
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.370
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.370
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021168 0 0 0 0 0 0 0 0 0 0 123 45
2021/2022636 84 70 22 28 24 29 26 35 18 49 44 207
2022/2023634 60 64 23 87 92 88 46 50 67 8 37 12
2023/2024436 27 33 15 10 32 64 22 48 12 16 10 147
2024/20251.565 33 41 143 47 170 153 33 61 254 210 235 185
2025/20264.744 491 249 476 626 756 331 580 247 428 539 21 0
Totale 10.913